Published in Transplantation on January 27, 2009
Accommodation in renal transplantation: unanswered questions. Curr Opin Organ Transplant (2010) 0.87
An update on the impact of pre-transplant transfusions and allosensitization on time to renal transplant and on allograft survival. BMC Nephrol (2013) 0.87
New directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunity. Drugs (2014) 0.84
HLA antibody screening in kidney transplantation: current guidelines. Langenbecks Arch Surg (2013) 0.76
Excellent renal allograft survival in donor-specific antibody transplant patients--role of intravenous immunoglobulin and rabbit antithymocyte globulin. Transplantation (2009) 0.75
A Comparison of Two Types of Rabbit Antithymocyte Globulin Induction Therapy in Immunological High-Risk Kidney Recipients: A Prospective Randomized Control Study. PLoS One (2016) 0.75
Management of sensitized pediatric patients prior to renal transplantation. Pediatr Nephrol (2016) 0.75
Utilization of elderly donors in living donor liver transplantation: when more is less? Liver Transpl (2011) 2.22
Impact of PTEN protein expression on benefit from adjuvant trastuzumab in early-stage human epidermal growth factor receptor 2-positive breast cancer in the North Central Cancer Treatment Group N9831 trial. J Clin Oncol (2013) 2.15
Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates. Transplantation (2013) 2.10
Asystole to cross-clamp period predicts development of biliary complications in liver transplantation using donation after cardiac death donors. Transpl Int (2012) 2.10
Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors. Liver Transpl (2012) 1.92
Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation. Liver Transpl (2009) 1.69
Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation. Transplantation (2004) 1.50
Hepatorenal syndrome: pathophysiology and management. Clin J Am Soc Nephrol (2006) 1.50
Serum fibrosis markers can predict rapid fibrosis progression after liver transplantation for hepatitis C. Liver Transpl (2008) 1.49
Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus. Liver Transpl (2011) 1.45
Results of a prospective randomized trial of sirolimus conversion in kidney transplant recipients on early corticosteroid withdrawal. Transplantation (2011) 1.42
Recurrent liver failure caused by IgG4 associated cholangitis. Ann Hepatol (2011) 1.42
Gallbladder carcinosarcoma: a case report and literature review. J Gastrointest Surg (2005) 1.37
Antibody immunosuppressive therapy in solid-organ transplant: Part I. MAbs (2011) 1.24
Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation. Ann Surg (2002) 1.24
Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancer. Breast Cancer Res (2012) 1.21
Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experience. Liver Transpl (2009) 1.21
C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the north central cancer treatment group N9831 adjuvant trastuzumab trial. J Clin Oncol (2011) 1.21
Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part I. Liver Transpl (2002) 1.12
Extrahepatic portal biliopathy: proposed etiology on the basis of anatomic and clinical features. Radiology (2010) 1.10
Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation (2004) 1.07
Outcomes after liver transplant in patients aged 70 years or older compared with those younger than 60 years. Mayo Clin Proc (2009) 1.07
Gene expression, single nucleotide variant and fusion transcript discovery in archival material from breast tumors. PLoS One (2013) 1.07
Simultaneous liver-kidney transplantation from donation after cardiac death donors: is there a better way to use these organs? Transplantation (2015) 1.05
Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis. Breast Cancer Res (2013) 1.03
Identification of patients best suited for combined liver-kidney transplantation: part II. Liver Transpl (2002) 1.01
De novo tumors after liver transplantation: a single-institution experience. Liver Transpl (2002) 1.00
Review of major clinical trials with mycophenolate mofetil in renal transplantation. Transplantation (2005) 1.00
Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study. Transplantation (2003) 1.00
Comparison of kidney function between donation after cardiac death and donation after brain death kidney transplantation. Transplantation (2013) 0.99
Prognosis and outcome of small (<=1 cm), node-negative breast cancer on the basis of hormonal and HER-2 status. Oncologist (2010) 0.99
Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy. Ann Surg Oncol (2012) 0.97
Breast medical oncologists' use of standard prognostic factors to predict a 21-gene recurrence score. Oncologist (2011) 0.94
Small bowel transit and gastric emptying after biliodigestive anastomosis using the uncut jejunal loop. Am J Surg (2003) 0.92
Peritonitis after liver transplantation: Incidence, risk factors, microbiology profiles, and outcome. Liver Transpl (2006) 0.91
Reversible non-ischaemic cardiomyopathy and left ventricular dysfunction after liver transplantation: a single-centre experience. Liver Int (2014) 0.90
Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients. Liver Transpl (2002) 0.90
Correlation between intraoperative blood flows and hepatic artery strictures in liver transplantation. Liver Transpl (2002) 0.90
Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years. Transplantation (2003) 0.89
Long-term outcomes of donation after cardiac death liver allografts from a single center. Clin Transplant (2009) 0.89
Is a mandatory intensive care unit stay needed after liver transplantation? Feasibility of fast-tracking to the surgical ward after liver transplantation. Liver Transpl (2012) 0.88
Use of middle hepatic vein in right lobe living donor liver transplantation. Transpl Int (2009) 0.88
Pharmacotherapeutic options for the management of human polyomaviruses. Adv Exp Med Biol (2006) 0.87
Long-term experience with simultaneous kidney-pancreas transplantation with portal-enteric drainage and tacrolimus/mycophenolate mofetil-based immunosuppression. Clin Transplant (2003) 0.86
Inferior long-term outcomes of liver-kidney transplantation using donation after cardiac death donors: single-center and organ procurement and transplantation network analyses. Liver Transpl (2014) 0.85
Preemptive living donor kidney transplantation: do the benefits extend to all recipients? Transplantation (2007) 0.85
Surgical site infection after liver transplantation: risk factors and association with graft loss or death. Transplantation (2009) 0.85
Kidney transplantation after previous liver transplantation: analysis of the organ procurement transplant network database. Transplantation (2011) 0.85
Antibody immunosuppressive therapy in solid organ transplant: Part II. MAbs (2010) 0.84
Proteolysis breaks tolerance toward intact α345(IV) collagen, eliciting novel anti-glomerular basement membrane autoantibodies specific for α345NC1 hexamers. J Immunol (2013) 0.84
The long-term management of pancreas transplantation. Transplantation (2006) 0.84
Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock. Pharmacotherapy (2004) 0.83
A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation (2002) 0.83
Role of apoptosis in fibrogenesis. Nephron (2002) 0.83
Impact of c-MYC protein expression on outcome of patients with early-stage HER2+ breast cancer treated with adjuvant trastuzumab NCCTG (alliance) N9831. Clin Cancer Res (2013) 0.82
Anesthesia for combined cardiac surgery and liver transplant. J Cardiothorac Vasc Anesth (2009) 0.82
Assessing the efficacy of kidney paired donation--performance of an integrated three-site program. Transplantation (2014) 0.81
Primary liver transplantation vs liver resection followed by transplantation for transplantable hepatocellular carcinoma: Liver functional quality and tumor characteristics matter. World J Gastrointest Surg (2013) 0.80
Proteinuria following sirolimus conversion is associated with deterioration of kidney function in liver transplant recipients. Transplantation (2012) 0.80
Primary alveolar soft-part sarcoma of the liver: anomalous presentation of a rare disease. Am Surg (2008) 0.80
The challenges of providing renal replacement therapy in decompensated liver cirrhosis. Blood Purif (2012) 0.79
Outcomes following liver transplantation in intensive care unit patients. World J Hepatol (2013) 0.79
Early allograft dysfunction in liver transplantation with donation after cardiac death donors results in inferior survival. Liver Transpl (2014) 0.79
Combined kidney liver transplant in the MELD era: where are we going? Liver Transpl (2005) 0.79
Perceptions of the donation process from adult-to-adult living liver donors. Prog Transplant (2003) 0.78
Emergent, controlled lumbar drainage for intracranial pressure monitoring during orthotopic liver transplantation. Neurocrit Care (2011) 0.78
Correction: Folate receptor-α (FOLR1) expression and function in triple negative tumors. PLoS One (2015) 0.78
Prospective, randomized evaluation of a cuffed expanded polytetrafluoroethylene graft for hemodialysis vascular access. Surgery (2002) 0.78
Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survival. Liver Transpl (2007) 0.78
Surgical site infections after liver retransplantation: incidence and risk factors. Liver Transpl (2014) 0.78
Pancreas transplant venous thrombosis: role of endovascular interventions for graft salvage. Cardiovasc Intervent Radiol (2009) 0.78
Preexisting atrial fibrillation and cardiac complications after liver transplantation. Liver Transpl (2015) 0.77
Hepatorenal syndrome in the intensive care unit. J Intensive Care Med (2011) 0.77
Impact of early conversion from tacrolimus to sirolimus on chronic allograft changes in kidney recipients on rapid steroid withdrawal. Transplantation (2012) 0.77
Liver transplantation for acute Budd-Chiari syndrome in identical twin sisters with Factor V leiden mutation. Transplantation (2003) 0.77
Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med (2003) 0.76